Medical Condition News

RSS
Wayne State University awards $1.8 million for development of multidisciplinary research groups

Wayne State University awards $1.8 million for development of multidisciplinary research groups

African-Americans with Medicaid are less likely to receive LKT than patients with private insurance

African-Americans with Medicaid are less likely to receive LKT than patients with private insurance

New $11 million grant for lowering stroke risk among black and young populations

New $11 million grant for lowering stroke risk among black and young populations

Bacterial DNA more likely to integrate in the genome of tumors than in normal healthy cells

Bacterial DNA more likely to integrate in the genome of tumors than in normal healthy cells

Young people need to wise up and turn the volume down on their earbuds, says audiologist

Young people need to wise up and turn the volume down on their earbuds, says audiologist

Residents in anesthesiology training programs have high rates of burnout and depression

Residents in anesthesiology training programs have high rates of burnout and depression

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

NeuroSigma's Monarch eTNS System to make Canadian debut at 30th International Epilepsy Congress

NeuroSigma's Monarch eTNS System to make Canadian debut at 30th International Epilepsy Congress

Weill Cornell public health study sheds light on hidden cost of terrorism

Weill Cornell public health study sheds light on hidden cost of terrorism

TSRI neuroscientists fill in significant gap in the understanding of how neurons mature

TSRI neuroscientists fill in significant gap in the understanding of how neurons mature

Th17 lymphocyte: The master coordinator of cellular inflammation in vessel wall

Th17 lymphocyte: The master coordinator of cellular inflammation in vessel wall

Alnylam presents new pre-clinical data of ALN-CC5 for treatment of complement-mediated diseases

Alnylam presents new pre-clinical data of ALN-CC5 for treatment of complement-mediated diseases

Researchers report therapeutic strategy that appears to destroy drug-resistant melanomas

Researchers report therapeutic strategy that appears to destroy drug-resistant melanomas

Research findings suggest potent new therapeutic target for certain types of cancer

Research findings suggest potent new therapeutic target for certain types of cancer

Combination therapy with myxoma virus and rapamycin can kill glioblastoma multiforme

Combination therapy with myxoma virus and rapamycin can kill glioblastoma multiforme

TSRI scientists find dual inhibitor that attacks two enzymes associated with Parkinson's disease

TSRI scientists find dual inhibitor that attacks two enzymes associated with Parkinson's disease

Scientists use stem-cell technology to create research cell line from PDAC patient

Scientists use stem-cell technology to create research cell line from PDAC patient

Duke Medicine researchers identify molecular target to prevent onset of epilepsy

Duke Medicine researchers identify molecular target to prevent onset of epilepsy

New treatment option for patients with aortic stenosis

New treatment option for patients with aortic stenosis

MIT study shows that SIRT1 gene plays key role in controlling circadian rhythms

MIT study shows that SIRT1 gene plays key role in controlling circadian rhythms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.